Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGC NASDAQ:CRON OTCMKTS:STDAF NASDAQ:TLRY NYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.37-1.4%$1.29$0.77▼$5.80$333.39M0.7722.56 million shs14.76 million shsCRONCronos Group$2.53-1.9%$2.31$1.60▼$2.77$987.86M1.133.01 million shs1.30 million shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$1.12+5.7%$0.91$0.35▼$1.88$1.17B2.0360.94 million shs46.52 million shsUSNAUSANA Health Sciences$30.56-1.0%$31.09$23.10▼$41.83$563.87M0.64107,758 shs132,472 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-1.44%-6.16%-16.46%-7.43%-70.91%CRONCronos Group-1.94%+1.20%-3.44%+31.09%+16.06%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands+5.66%-5.88%-10.40%+177.23%-34.88%USNAUSANA Health Sciences-0.95%-3.83%-2.71%+3.24%-18.07%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.37-1.4%$1.29$0.77▼$5.80$333.39M0.7722.56 million shs14.76 million shsCRONCronos Group$2.53-1.9%$2.31$1.60▼$2.77$987.86M1.133.01 million shs1.30 million shsSTDAFSTADA Arzneimittel Aktiengesellschaft$110.42$110.42$75.15▼$115.00$6.88B0.38180 shsN/ATLRYTilray Brands$1.12+5.7%$0.91$0.35▼$1.88$1.17B2.0360.94 million shs46.52 million shsUSNAUSANA Health Sciences$30.56-1.0%$31.09$23.10▼$41.83$563.87M0.64107,758 shs132,472 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth-1.44%-6.16%-16.46%-7.43%-70.91%CRONCronos Group-1.94%+1.20%-3.44%+31.09%+16.06%STDAFSTADA Arzneimittel Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands+5.66%-5.88%-10.40%+177.23%-34.88%USNAUSANA Health Sciences-0.95%-3.83%-2.71%+3.24%-18.07%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 1.33SellN/AN/ACRONCronos Group 0.00N/AN/AN/ASTDAFSTADA Arzneimittel Aktiengesellschaft 0.00N/AN/AN/ATLRYTilray Brands 2.33Hold$1.9472.99% UpsideUSNAUSANA Health Sciences 2.00Hold$36.0017.80% UpsideCurrent Analyst Ratings BreakdownLatest CGC, TLRY, STDAF, CRON, and USNA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/25/2025TLRYTilray BrandsJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$1.50 ➝ $2.008/12/2025CGCCanopy GrowthZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold7/29/2025TLRYTilray BrandsZelman & AssociatesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral(Data available from 9/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$274.92M1.20N/AN/A$1.90 per share0.72CRONCronos Group$130.28M7.44$0.00 per share5,544.57$2.90 per share0.87STDAFSTADA Arzneimittel Aktiengesellschaft$3.84B1.79$11.12 per share9.93$23.11 per share4.78TLRYTilray Brands$210.48M5.86$0.15 per share7.33$1.40 per share0.80USNAUSANA Health Sciences$899.22M0.62$3.74 per share8.18$27.92 per share1.09Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$429.86M-$3.03N/AN/AN/A-155.76%-89.93%-44.24%11/14/2025 (Estimated)CRONCronos Group$41.08M$0.0550.6084.33N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)STDAFSTADA Arzneimittel Aktiengesellschaft$292.15MN/A0.00∞N/AN/AN/AN/AN/ATLRYTilray Brands-$2.19B-$2.31N/AN/AN/A-265.69%-6.83%-5.45%10/9/2025 (Estimated)USNAUSANA Health Sciences$42.03M$1.8016.9810.570.983.79%9.48%6.95%10/28/2025 (Estimated)Latest CGC, TLRY, STDAF, CRON, and USNA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/9/2025Q1 2026TLRYTilray Brands-$0.03N/AN/AN/A$205.75 millionN/A8/8/2025Q1 2026CGCCanopy Growth-$0.15-$0.14+$0.01-$0.16$64.98 million$52.98 million8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 million7/28/2025Q4 2025TLRYTilray Brands-$0.03$0.02+$0.05-$1.30$250.41 million$224.54 million7/22/2025Q2 2025USNAUSANA Health Sciences$0.54$0.74+$0.20$0.52$225.20 million$235.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ASTDAFSTADA Arzneimittel AktiengesellschaftN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.593.072.12CRONCronos GroupN/A24.6523.53STDAFSTADA Arzneimittel Aktiengesellschaft2.231.540.99TLRYTilray Brands0.202.461.49USNAUSANA Health SciencesN/A2.151.47Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands9.35%USNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth0.16%CRONCronos Group7.30%STDAFSTADA Arzneimittel AktiengesellschaftN/ATLRYTilray Brands0.60%USNAUSANA Health Sciences0.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth3,150239.85 million239.47 millionOptionableCRONCronos Group450382.89 million354.94 millionOptionableSTDAFSTADA Arzneimittel Aktiengesellschaft12,50062.34 millionN/ANot OptionableTLRYTilray Brands2,8421.10 billion1.09 billionOptionableUSNAUSANA Health Sciences1,70018.27 million18.16 millionOptionableCGC, TLRY, STDAF, CRON, and USNA HeadlinesRecent News About These CompaniesUSANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven ResultsSeptember 11 at 7:47 AM | prnewswire.comUSANA Health Sciences, Inc. $USNA Shares Acquired by Jacobs Levy Equity Management Inc.September 11 at 4:07 AM | marketbeat.comPetrus Trust Company LTA Takes Position in USANA Health Sciences, Inc. $USNASeptember 10 at 5:27 AM | marketbeat.com5 Undervalued Stocks That Are Worth Buying in SeptemberSeptember 9, 2025 | zacks.comUSANA Expands Its Nutritionals Line With Powerful New Products and Enhanced FormulasSeptember 9, 2025 | prnewswire.com12,828 Shares in USANA Health Sciences, Inc. $USNA Bought by Walleye Capital LLCSeptember 6, 2025 | marketbeat.comMagnetar Financial LLC Purchases New Holdings in USANA Health Sciences, Inc. $USNASeptember 4, 2025 | marketbeat.comNuveen LLC Makes New Investment in USANA Health Sciences, Inc. $USNASeptember 4, 2025 | marketbeat.comKevin Guest Encourages Self-Improvement as Path to Harmony, FulfillmentSeptember 2, 2025 | prnewswire.comCharles Schwab Investment Management Inc. Increases Stock Position in USANA Health Sciences, Inc. $USNAAugust 31, 2025 | marketbeat.comAmerican Century Companies Inc. Has $6.88 Million Stock Position in USANA Health Sciences, Inc. $USNAAugust 30, 2025 | marketbeat.comVanguard Group Inc. Cuts Stock Holdings in USANA Health Sciences, Inc. $USNAAugust 29, 2025 | marketbeat.comUSNA or STVN: Which Is the Better Value Stock Right Now?August 28, 2025 | zacks.comVersor Investments LP Buys New Stake in USANA Health Sciences, Inc. $USNAAugust 24, 2025 | marketbeat.comUSANA Introduces New and Upgraded Products, Along with Its Health Professional Advisory CouncilAugust 22, 2025 | prnewswire.com4 Value Stocks Every Investor Should Hold in Volatile TimesAugust 21, 2025 | zacks.comShould Value Investors Buy USANA Health Sciences (USNA) Stock?August 21, 2025 | zacks.comValue Investing: 5 Undervalued Stocks Worth Adding to Your PortfolioAugust 21, 2025 | zacks.com32,269 Shares in USANA Health Sciences, Inc. $USNA Bought by Connor Clark & Lunn Investment Management Ltd.August 19, 2025 | marketbeat.comUSNA vs. STVN: Which Stock Is the Better Value Option?August 12, 2025 | zacks.comUSANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 1,058 SharesAugust 9, 2025 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 2025Tilray's High Hopes: The Catalyst Driving Cannabis StocksBy Jeffrey Neal Johnson | August 21, 2025Deeply Undervalued, Micron Technologies Stock Isn’t Pricing in AIBy Thomas Hughes | August 14, 2025Micron Stock Still Cheap Despite 25% Rally, Analysts SayBy Gabriel Osorio-Mazilli | August 19, 2025Why Micron Stock Could Outperform NVIDIA in 2025By Gabriel Osorio-Mazilli | September 12, 2025CGC, TLRY, STDAF, CRON, and USNA Company DescriptionsCanopy Growth NASDAQ:CGC$1.37 -0.02 (-1.44%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.37 +0.00 (+0.07%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.53 -0.05 (-1.94%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.52 0.00 (-0.20%) As of 09/12/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.STADA Arzneimittel Aktiengesellschaft OTCMKTS:STDAF$110.42 0.00 (0.00%) As of 10/24/2022STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.Tilray Brands NASDAQ:TLRY$1.12 +0.06 (+5.66%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.12 +0.00 (+0.45%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.USANA Health Sciences NYSE:USNA$30.56 -0.30 (-0.97%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$30.48 -0.07 (-0.25%) As of 09/12/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Not Just NVDA: 3 Semiconductor Stocks Struggling This Quarter Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
